Precision BioSciences, Inc.
DTILFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
69
Cost of Revenue
0
Gross Profit
69
Gross Margin
100.0%
Operating Income
-26
Operating Margin
-38.1%
Net Income
7
Net Margin
10.4%
EPS (Basic)
$1.05
EPS (Diluted)
$1.04
EBITDA
14
EBITDA Margin
19.7%
2023
12/31/2023
Revenue
49
Cost of Revenue
0
Gross Profit
49
Gross Margin
100.0%
Operating Income
-44
Operating Margin
-89.8%
Net Income
-61
Net Margin
-125.8%
EPS (Basic)
$-15.96
EPS (Diluted)
$-15.96
EBITDA
-32
EBITDA Margin
-65.8%
2022
12/31/2022
Revenue
25
Cost of Revenue
0
Gross Profit
25
Gross Margin
100.0%
Operating Income
-62
Operating Margin
-248.3%
Net Income
-112
Net Margin
-444.8%
EPS (Basic)
$-38.10
EPS (Diluted)
$-38.10
EBITDA
-63
EBITDA Margin
-250.2%
2021
12/31/2021
Revenue
116
Cost of Revenue
0
Gross Profit
116
Gross Margin
100.0%
Operating Income
-39
Operating Margin
-34.1%
Net Income
-31
Net Margin
-26.5%
EPS (Basic)
$-15.60
EPS (Diluted)
$-15.60
EBITDA
-20
EBITDA Margin
-17.5%
2020
12/31/2020
Revenue
24
Cost of Revenue
0
Gross Profit
24
Gross Margin
100.0%
Operating Income
-110
Operating Margin
-452.2%
Net Income
-109
Net Margin
-448.9%
EPS (Basic)
$-62.85
EPS (Diluted)
$-62.85
EBITDA
-99
EBITDA Margin
-408.5%